ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1117–1128 of 2020 project topics
Pharmacogenomic Response Prediction for Obesity Medications
A clinical decision support software that predicts individual genetic response to GLP-1 agonists, weight-loss medications, and metabolic drugs before prescription. Revenue streams include licensing fees from pharmaceutical companies, partnerships with pharmacy benefit managers, and per-patient analysis fees from healthcare providers optimizing drug efficacy.
Genetics of Obesity-Related Complications Click to view more details →
Insulin Resistance Genetic Predisposition Commercial Testing Kit
A direct-to-consumer and B2B genetic test identifying genetic architectures underlying insulin resistance in obese individuals, with personalized nutrition and lifestyle recommendations. The business model generates revenue through test sales, data licensing to pharmaceutical research firms, and premium wellness app subscriptions with tailored intervention protocols.
Genetics of Obesity-Related Complications Click to view more details →
Inflammation-Driven Obesity Complication Genomic Biomarker Service
A laboratory-based genomic profiling service that quantifies genetic markers of chronic inflammation associated with obesity complications, including arthritis and autoimmune disease progression. This generates revenue through clinical laboratory partnerships, insurance reimbursement billing, and licensing biomarker intellectual property to diagnostic and pharmaceutical companies.
Genetics of Obesity-Related Complications Click to view more details →
Cancer Risk Stratification in Obese Population Genetic Platform
An integrated genetic analytics platform that identifies obesity-cancer syndrome predisposition genes and calculates personalized cancer risk scores for surveillance and prevention planning. Commercial value derives from licensing agreements with oncology centers, health systems implementing obesity-cancer prevention programs, and partnerships with cancer screening and pharmaceutical organizations.
Genetics of Obesity-Related Complications Click to view more details →
Clinical NGS Platform Comparison and Validation
Comparing diagnostic performance of Illumina, Ion Torrent, and other NGS platforms for clinical genetic testing applications.
Genetic Testing Platform Technologies Click to view more details →
Rapid Turnaround Sequencing Technology Development
Developing ultrarapid sequencing workflows using nanopore technology for achieving genetic diagnoses within hours in urgent clinical settings.
Genetic Testing Platform Technologies Click to view more details →
Point-of-Care Genetic Testing Device Development
Evaluating portable genetic testing platforms for use in resource-limited settings and point-of-care applications for common genetic conditions.
Genetic Testing Platform Technologies Click to view more details →
Microarray Technology for Clinical Cytogenomics
Optimizing SNP array platforms and analysis workflows for clinical chromosomal microarray analysis including CNV detection and UPD identification.
Genetic Testing Platform Technologies Click to view more details →
Liquid Biopsy Platform Integration and Commercialization Strategy
Enterprise SaaS platform that integrates cell-free DNA and circulating tumor DNA analysis workflows with laboratory information systems for non-invasive cancer screening and monitoring. Enables laboratories to launch high-margin liquid biopsy testing services while reducing infrastructure costs through cloud-based analytics and automated result reporting.
Genetic Testing Platform Technologies Click to view more details →
Pharmacogenomics Testing Workflow Automation and Clinical Decision Support
Clinical decision support software that automates pharmacogenomic test interpretation and delivers personalized medication recommendations integrated directly into electronic health record systems. Generates recurring revenue through per-test licensing fees while improving patient outcomes and reducing adverse drug event costs for healthcare systems.
Genetic Testing Platform Technologies Click to view more details →
Carrier Screening Panel Customization and Direct-to-Consumer Distribution Platform
Modular SaaS platform enabling genetic laboratories to create customized carrier screening panels targeting specific ethnic populations and disease prevalence patterns for direct-to-consumer and employer wellness programs. Expands addressable market by democratizing genetic testing access while capturing high-margin direct sales revenue and data insights.
Genetic Testing Platform Technologies Click to view more details →
Real-Time Genetic Data Quality Control and Laboratory Compliance Monitoring
Cloud-based quality assurance software that continuously monitors sequencing data quality metrics, variant calling accuracy, and regulatory compliance across distributed laboratory networks using machine learning algorithms. Reduces turnaround time, minimizes repeat testing costs, and creates subscription-based revenue through per-sample or per-laboratory licensing models.
Genetic Testing Platform Technologies Click to view more details →